PE20070404A1 - Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona - Google Patents
Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesteronaInfo
- Publication number
- PE20070404A1 PE20070404A1 PE2006000915A PE2006000915A PE20070404A1 PE 20070404 A1 PE20070404 A1 PE 20070404A1 PE 2006000915 A PE2006000915 A PE 2006000915A PE 2006000915 A PE2006000915 A PE 2006000915A PE 20070404 A1 PE20070404 A1 PE 20070404A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- sulfonamide
- progesterone receptor
- modulators
- cyanopyrrol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS DE FORMULA (I) DONDE R1 ES H, CN, SO2-ALQUILO(C1-C6), C(O)-ALQUILO(C1-C6), ENTRE OTROS; R2 ES H, ALQUILO(C1-C6), CICLOALQUILO(C3-C6), ENTRE OTROS; R3, R4, R5 Y R6 SON CADA UNO H, HALOGENO, CN, ALQUILO(C1-C6), ENTRE OTROS; R7 ES H, ALQUILO(C1-C6), ALQUENILO(C2-C6), ALQUINILO(C2-C6), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N-[4-(5-CIANO-1-METIL-1H-PIRROL-2-IL)FENIL]PROPANO-1-SULFONAMIDA, N-[4-(5-CIANO-1-METIL-1H-PIRROL-2-IL)FENIL]-N-(METILSULFONIL)METANSULFONAMIDA, N-[4-(5-CIANO-1-METIL-1H-PIRROL-2-IL)FENIL]BUTAN-1-SULFONAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES DEL RECEPTOR DE PROGESTERONA SIENDO UTILES EN EL TRATAMIENTO DE DISMENORREA, SANGRADO UTERINO DISFUNCIONAL, TERAPIA DE REEMPLAZO HORMONAL
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70400905P | 2005-07-29 | 2005-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070404A1 true PE20070404A1 (es) | 2007-05-10 |
Family
ID=37309001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000915A PE20070404A1 (es) | 2005-07-29 | 2006-07-26 | Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona |
Country Status (22)
Country | Link |
---|---|
US (1) | US7291643B2 (es) |
EP (1) | EP1910285A1 (es) |
JP (1) | JP5185114B2 (es) |
KR (1) | KR20080031915A (es) |
CN (1) | CN101233104A (es) |
AR (1) | AR056005A1 (es) |
AU (1) | AU2006275833B2 (es) |
BR (1) | BRPI0614412A2 (es) |
CA (1) | CA2612977A1 (es) |
CR (1) | CR9627A (es) |
EC (1) | ECSP088147A (es) |
GT (1) | GT200600336A (es) |
HN (1) | HN2008000135A (es) |
IL (1) | IL188314A (es) |
MX (1) | MX2008001338A (es) |
NO (1) | NO20076683L (es) |
PE (1) | PE20070404A1 (es) |
RU (1) | RU2007148077A (es) |
SA (1) | SA06270246B1 (es) |
TW (1) | TW200734302A (es) |
UA (1) | UA92500C2 (es) |
WO (1) | WO2007016212A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20070182A1 (es) * | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
TW200848019A (en) | 2007-03-06 | 2008-12-16 | Wyeth Corp | Aryl sulfonamides useful for modulation of the progesterone receptor |
TW200848021A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Sulfonylated heterocycles useful for modulation of the progesterone receptor |
EA201070715A1 (ru) * | 2007-12-20 | 2011-02-28 | Тева Вимен'С Хелс, Инк. | Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции |
EP2914253B1 (en) | 2012-11-05 | 2018-01-03 | NantBioScience, Inc. | Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680413A (en) * | 1986-01-17 | 1987-07-14 | Nippon Soda Co., Ltd. | Process for the production of 3-phenyl-4-cyanopyrroles |
US5455263A (en) * | 1987-07-29 | 1995-10-03 | American Cyanamid Company | Methods for the control and the protection of warm-blooded animals against infestation and infection by helminths, acarids and arthropod endo- and ectoparasites |
EP0339342A1 (de) * | 1988-04-23 | 1989-11-02 | Bayer Ag | N-Substituierte N-Amino-pyrrole |
GB8903592D0 (en) * | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
DE4036645A1 (de) | 1990-11-16 | 1992-05-21 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung |
JP2699024B2 (ja) | 1990-11-22 | 1998-01-19 | 富士写真フイルム株式会社 | 新規な色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料 |
US5236925A (en) * | 1991-10-24 | 1993-08-17 | American Home Products Corporation | Fused pyrimidines as angiotensin II antagonists |
US5187168A (en) * | 1991-10-24 | 1993-02-16 | American Home Products Corporation | Substituted quinazolines as angiotensin II antagonists |
WO1994017059A1 (en) | 1993-01-29 | 1994-08-04 | Nippon Soda Co., Ltd. | Heterocyclic derivative |
RU2166941C2 (ru) * | 1995-06-07 | 2001-05-20 | Ниппон Синяку Ко., Лтд. | Производные пиррола и фармацевтическая композиция на их основе |
US6013421A (en) * | 1996-07-19 | 2000-01-11 | Fuji Photo Film Co., Ltd. | Silver halide photographic light-sensitive material and image-forming method |
US20010007867A1 (en) * | 1999-12-13 | 2001-07-12 | Yuhpyng L. Chen | Substituted 6,5-hetero-bicyclic derivatives |
US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
DE60210755T2 (de) * | 2001-03-09 | 2006-11-16 | Pfizer Products Inc., Groton | Triazolopyridine als entzündungshemmende mittel |
WO2002072576A1 (en) * | 2001-03-09 | 2002-09-19 | Pfizer Products Inc. | Benzimidazole anti-inflammatory compounds |
ES2247271T3 (es) * | 2001-04-04 | 2006-03-01 | Pfizer Products Inc. | Nuevos benzotriazoles como compuestos antiinflamatorios. |
BR0316191A (pt) | 2002-11-11 | 2005-09-27 | Bayer Healthcare Ag | Derivados de amino alcano de fenila ou heteroarila como antagonistas de receptor de ip |
WO2004073594A2 (fr) | 2003-02-12 | 2004-09-02 | L'oreal | Utilisation d’un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres |
BRPI0510278A (pt) * | 2004-04-27 | 2007-10-30 | Wyeth Corp | método para produzir compostos, produto, e, composto |
GT200500183A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
GT200500185A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos |
-
2006
- 2006-07-26 PE PE2006000915A patent/PE20070404A1/es not_active Application Discontinuation
- 2006-07-27 GT GT200600336A patent/GT200600336A/es unknown
- 2006-07-27 KR KR1020087002371A patent/KR20080031915A/ko not_active Application Discontinuation
- 2006-07-27 TW TW095127519A patent/TW200734302A/zh unknown
- 2006-07-27 WO PCT/US2006/029125 patent/WO2007016212A1/en active Application Filing
- 2006-07-27 CN CNA2006800277588A patent/CN101233104A/zh active Pending
- 2006-07-27 JP JP2008524136A patent/JP5185114B2/ja not_active Expired - Fee Related
- 2006-07-27 BR BRPI0614412A patent/BRPI0614412A2/pt not_active IP Right Cessation
- 2006-07-27 RU RU2007148077/04A patent/RU2007148077A/ru not_active Application Discontinuation
- 2006-07-27 AR ARP060103257A patent/AR056005A1/es not_active Application Discontinuation
- 2006-07-27 EP EP06774705A patent/EP1910285A1/en not_active Withdrawn
- 2006-07-27 CA CA002612977A patent/CA2612977A1/en not_active Abandoned
- 2006-07-27 MX MX2008001338A patent/MX2008001338A/es active IP Right Grant
- 2006-07-27 US US11/494,226 patent/US7291643B2/en not_active Expired - Fee Related
- 2006-07-27 UA UAA200801075A patent/UA92500C2/ru unknown
- 2006-07-27 AU AU2006275833A patent/AU2006275833B2/en not_active Ceased
- 2006-07-29 SA SA06270246A patent/SA06270246B1/ar unknown
-
2007
- 2007-12-20 IL IL188314A patent/IL188314A/en not_active IP Right Cessation
- 2007-12-20 CR CR9627A patent/CR9627A/es not_active Application Discontinuation
- 2007-12-28 NO NO20076683A patent/NO20076683L/no not_active Application Discontinuation
-
2008
- 2008-01-28 HN HN2008000135A patent/HN2008000135A/es unknown
- 2008-01-28 EC EC2008008147A patent/ECSP088147A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR056005A1 (es) | 2007-09-12 |
JP2009502947A (ja) | 2009-01-29 |
CN101233104A (zh) | 2008-07-30 |
GT200600336A (es) | 2007-05-28 |
AU2006275833B2 (en) | 2012-04-26 |
IL188314A0 (en) | 2008-04-13 |
EP1910285A1 (en) | 2008-04-16 |
ECSP088147A (es) | 2008-02-20 |
MX2008001338A (es) | 2008-03-25 |
AU2006275833A1 (en) | 2007-02-08 |
JP5185114B2 (ja) | 2013-04-17 |
TW200734302A (en) | 2007-09-16 |
CA2612977A1 (en) | 2007-02-08 |
BRPI0614412A2 (pt) | 2016-11-22 |
US7291643B2 (en) | 2007-11-06 |
CR9627A (es) | 2008-03-06 |
HN2008000135A (es) | 2010-08-19 |
WO2007016212A1 (en) | 2007-02-08 |
NO20076683L (no) | 2008-02-04 |
UA92500C2 (ru) | 2010-11-10 |
SA06270246B1 (ar) | 2010-11-22 |
KR20080031915A (ko) | 2008-04-11 |
US20070027126A1 (en) | 2007-02-01 |
IL188314A (en) | 2012-09-24 |
RU2007148077A (ru) | 2009-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20070341A1 (es) | Derivados de pirrol como moduladores del receptor de progesterona | |
PE20071245A1 (es) | COMPUESTOS INDOL SULFONAMIDA COMO MODULADORES DEL RECEPTOR DE PROGESTERONA SELECTIVOS (SPRMs) | |
PE20090890A1 (es) | Compuestos derivados de 1-(2,3-dihidrobenzo[1,4]dioxin-2-ilmetil)azaciclos como antagonistas del suptipo adrenoreceptor alfa2c | |
PE20070404A1 (es) | Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona | |
PE20141375A1 (es) | Activadores de glucoquinasa | |
PE20060438A1 (es) | Compuestos de urea como moduladores del sarcomero | |
PE20070528A1 (es) | Compuestos heterociclicos como ligandos del receptor vaniloide del subtipo 1 | |
PE20061353A1 (es) | Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa | |
PE20080418A1 (es) | Compuestos y composiciones como moduladores de la via de hedgehog | |
PE20071320A1 (es) | Moduladores de receptores cannabinoides | |
PE20090482A1 (es) | Derivados heterociclicos como antagonistas del receptor ccr2 | |
PE20060297A1 (es) | Nuevos derivados fluoroglicosidicos de pirazoles como inhibidores de sglt 1 | |
NO20063470L (no) | Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister | |
AR039566A1 (es) | Inhibidores de la histona deacetilasa, composicion farmaceutica que los contiene y sus procesos de preparacion | |
AR076460A1 (es) | Antagonistas del receptor cxcr3 | |
PE20130242A1 (es) | Derivados de isoxazolo-piridina | |
PE20121050A1 (es) | Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog | |
PE20060623A1 (es) | Compuestos de sulfonamida como potenciadores del receptor de glutamato | |
PE20071095A1 (es) | Derivados policiclicos de indazol como inhibidores de erk | |
PE20090057A1 (es) | Compuestos y composiciones como moduladores de la actividad gpr119 | |
PE20091000A1 (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana | |
PE20081409A1 (es) | Antagonistas del receptor de progesterona | |
PE20090622A1 (es) | Nuevos derivados de bencimidazol sustituido | |
PE20160891A1 (es) | Moduladores de ror gamma (rory) | |
PE20091008A1 (es) | Derivados heterociclicos como moduladores de fosfoinositida 3-cinasa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |